Wart – Comprehensive Medical Guide
Overview
A wart is a small, benign skin growth caused by an infection with the human papillomavirus (HPV). Warts can appear on any part of the body but are most common on the hands, fingers, knees, and feet (plantar warts). They are non‑cancerous, usually painless, and often resolve on their own over months to years, though some people seek treatment for cosmetic reasons or discomfort.
Who it affects: Warts can occur at any age, but the highest incidence is seen in children and adolescents (ages 5‑15). Adults can also develop warts, especially on the hands and feet, and the risk rises again in people with weakened immune systems.
Prevalence: According to the Centers for Disease Control and Prevention (CDC), approximately 7–10 % of the U.S. population will develop a wart at some point in their lives [CDC, 2023]. In a population‑based study from the United Kingdom, the prevalence of common warts (verruca vulgaris) was reported as 3 % in children and 1 % in adults [British Journal of Dermatology, 2021].
Symptoms
Warts have characteristic appearances, but the exact look can vary depending on the type.
General features
- Size: Typically 1–5 mm, but can grow larger, especially with repeated trauma.
- Surface texture: Rough, grainy, or cauliflower‑like; may have a central black dot (thrombosed capillary).
- Color: Flesh‑colored, pink, brown, or gray.
- Pain: Most warts are painless; plantar warts can be tender when walking.
Type‑specific symptoms
- Common warts (verruca vulgaris): Dome‑shaped, rough surface, usually on hands or fingers.
- Plantar warts: Appear on the soles; may cause a hard, thickened area of skin (callus) and pain with pressure.
- Flat warts (verruca plana): Smooth, flat-topped lesions, often clustered on the face, neck, or legs.
- Filiform warts: Long, thin projections, commonly on eyelids, lips, or neck.
- Periungual warts: Grow around nails, potentially causing nail deformities.
Causes and Risk Factors
Etiology
All warts are caused by infection with one of more than 150 different HPV subtypes. The most common subtypes for skin warts are HPV 1, 2, 4, and 27. The virus enters the epidermis through tiny cuts or abrasions, where it infects keratinocytes (skin cells) and stimulates excessive growth.
Risk factors
- Age: Children & adolescents have higher exposure due to close contact.
- Skin trauma: Cuts, scrapes, or macerated skin (e.g., from swimming) increase entry points.
- Moist environments: Public showers, pools, and locker rooms favor virus survival.
- Immunosuppression: HIV, organ‑transplant patients, or those on systemic steroids have higher rates.
- Personal history: Having one wart increases the likelihood of developing more.
- Occupational exposure: Healthcare workers, athletes, and people who handle soil or animals may have increased risk.
Diagnosis
Diagnosis is primarily clinical—based on visual inspection and medical history.
Physical examination
- Dermatologist or primary‑care provider examines size, shape, surface, and location.
- Application of a dermatoscope may help differentiate warts from other lesions (e.g., molluscum, callus).
Additional tests (rarely needed)
- Biopsy: Considered if the lesion is atypical, rapidly changing, or if cancer is a concern.
- HPV typing: Molecular PCR testing can identify specific HPV subtypes, used mainly in research or immunocompromised patients.
Treatment Options
Because warts often resolve spontaneously, treatment is usually pursued for pain, functional impairment, or cosmetic reasons. Options range from self‑care measures to office‑based procedures.
Topical medications
- Salicylic acid (17‑40%): A keratolytic that softens the wart. Applied daily for 6‑12 weeks. Evidence: Systematic review found ~70 % clearance after 12 weeks of daily use (Cochrane, 2022).
- Prescription retinoids (tazarotene): Promote cell turnover; useful for flat warts.
- Topical immunotherapy (imiquimod 5% cream): Stimulates local immune response; reserved for refractory warts.
Cryotherapy
Liquid nitrogen is applied to freeze the wart (–196 °C). Multiple sessions (usually 2‑4) are often required. Cure rates range from 50–70 % (American Academy of Dermatology, 2021).
Electrosurgery & curettage
The wart tissue is scraped away (curettage) after local anesthetic, sometimes combined with electro‑coagulation. Effective for large or stubborn lesions but carries a small risk of scarring.
Laser therapy
Carbon dioxide (CO₂) or pulsed‑dye lasers vaporize wart tissue. Recommended when other methods fail.
Immunotherapy (in-office)
- Contact sensitizers: Dinitrochlorobenzene (DNCB) or squaric acid dibutylester (SADBE) applied to provoke an immune response that clears warts.
- Intralesional candida antigen: Small amounts injected into the wart; success rates up to 80 % in immunocompetent patients.
Other modalities
- Cantharidin: A blistering agent applied by a clinician; useful for children.
- Essential oils (tea tree, oregano): Limited evidence; not recommended as first‑line.
Lifestyle & home care
- Soaking the wart in warm water before applying salicylic acid improves absorption.
- Avoid picking or cutting the wart to reduce spread.
- Cover with a waterproof plaster if the wart is in a high‑friction area (e.g., plantar wart) to reduce pain.
Living with Warts
While warts are harmless, they can be socially or physically bothersome. Below are practical tips.
- Protect the area: Use waterproof bandages for plantar warts to lessen pressure and pain.
- Maintain skin hygiene: Keep hands clean and dry; change socks daily if you have foot warts.
- Avoid spreading: Do not share towels, razors, or footwear. Wash hands after touching a wart.
- Footwear: Wear flip‑flops in public showers and pool decks.
- Monitor changes: Note any growth, change in color, or pain; document with photos for follow‑up.
- Psychological impact: If warts cause anxiety or self‑esteem issues, discuss with a dermatologist or mental‑health professional; many patients find relief after successful treatment.
Prevention
Because HPV is highly contagious, prevention focuses on minimizing skin contact with the virus.
- Wash hands frequently with soap and water.
- Use protective gloves when handling potentially contaminated surfaces (e.g., communal gym equipment).
- Avoid walking barefoot in public locker rooms, pools, or showers.
- Keep cuts, abrasions, and athlete’s foot infections treated promptly.
- Do not pick at existing warts; this can spread the virus to adjacent skin.
- Consider HPV vaccination for adolescents (covers HPV 6, 11, 16, 18, and newer types). Although the vaccine is primarily aimed at preventing anogenital HPV, studies show a modest reduction in cutaneous warts among vaccinated youth (Lancet Infectious Diseases, 2020).
Complications
Most warts are benign, but untreated or mismanaged warts can lead to:
- Secondary bacterial infection: From scratching or maceration, presenting with redness, warmth, pus.
- Pain or functional limitation: Plantar warts can interfere with walking; periungual warts may impair nail growth.
- Scarring: Aggressive removal methods can cause permanent skin changes.
- Spread to other body sites: Autoinoculation—touching a wart and then another area—can create new lesions.
- Rare malignant transformation: Certain HPV types (especially 16, 18) are linked to skin cancers in immunocompromised patients, though this is exceedingly uncommon for typical cutaneous warts.
When to Seek Emergency Care
- Sudden, severe pain that does not improve with over‑the‑counter pain relievers.
- Rapid swelling, redness, or warmth around a wart suggestive of an acute infection (cellulitis).
- Fever, chills, or streaks of red extending from the lesion (signs of systemic infection).
- Signs of a ruptured wart that is bleeding heavily and does not stop after applying firm pressure for 10 minutes.
- Any wart that changes dramatically in size, shape, or color within days, especially if it becomes ulcerated or bleeds.
These symptoms may indicate complications that require prompt medical attention.
Sources: CDC (2023), Mayo Clinic (2022), American Academy of Dermatology (2021), Cochrane Review on Salicylic Acid (2022), British Journal of Dermatology (2021), Lancet Infectious Diseases (2020), WHO (2023).
```